Logo image
Prof. Dr. med. Holger Lode working place, University Hospital Greifswald
Prof. Dr. med. Holger Lode
Excellent
AiroScore
9.90

Prof. Dr. med. Holger Lode

pediatrics, pediatric hematology and oncology, intensive care
pediatrics, pediatric hematology and oncology, intensive care
User ScoreExperienceRatingPrice RangePublicationsOnline Consultations
98%31 years9.9/10$$$286No

Overview

Country, City
Germany, Greifswald
Health facility
University Hospital Greifswald
Medical unit
Department of pediatrics

About the doctor

Prof. Dr. med. Holger Lode is a highly experienced doctor with over 30 years of experience in the field of pediatrics, pediatric hematology, and oncology. He is currently working at the Department of Pediatrics at the University Hospital Greifswald in Germany. Dr. Lode has an impressive educational background, having studied medicine at renowned institutions such as the Eberhard Karls University of Tuebingen and Brown University. Throughout his career, Dr. Lode has made significant contributions to the field of pediatric oncology through his research and publications. He has published 286 scientific papers covering a wide range of topics, including social inequalities in pediatric cancer treatment and the development of novel immunotherapies for neuroblastoma, a type of childhood cancer. Dr. Lode's expertise and dedication to his field have earned him recognition and membership in prestigious organizations such as the International Society for Pediatric Oncology and the American Association for Cancer Research. He is also an active reviewer for several scientific journals. With his extensive experience, research contributions, and dedication to improving the treatment of pediatric cancers, Prof. Dr. med. Holger Lode is considered an exceptional doctor in the field. His expertise in pediatrics, pediatric hematology, and oncology, combined with his innovative research, make him a valuable asset to the medical community and a trusted practitioner for his patients.

Skills & Expertise

neuroblastoma
antibody
immunotherapy
cancer
dinutuximab
oncology
tumor
pediatrics
pediatric oncology
gene therapy
leukemia
refractory neuroblastoma
hematology
pediatric hematology
carcinoma
cell transplantation
relapsedrefractory neuroblastoma
antineuroblastoma immunotherapy
stem cell
chemotherapy
carcinoma metastases
colon carcinoma
ganglidiomab
glioblastoma
bone marrow
melanoma
bone
children
colon carcinoma metastases
metastatic neuroblastoma
malignancies
sarcoma
fenretinide
neuroectodermal tumors
glioblastoma multiforme
betabased immunotherapy
vaccines antineuroblastoma
immunocytokine therapy
interleukin therapy
ewing sarcoma
lymphoblastic leukaemia
hematopoietic stem
metastases bone marrow
mucoepidermoid carcinoma
aplastic anemia
splenic rupture
prostate carcinoma
colon cancer
aggressive metastasized neuroblastoma
metastatic ewing sarcoma

Resume

CV (Curriculum Vitae)

Education
  • 1986-1993 Studied human medicine at the Eberhard Karls University of Tuebingen and Brown University
  • 1993 Defense of the dissertation at the University of Tuebingen
  • 1996 Obtaining a license for medical practice by the State Medical Association of Baden-Wuerttemberg
  • 1993-1996 Research fellowship of the Department of pediatrics at the University Hospital Tuebingen
  • 1996-1999 Research fellowship of the German Research Foundation for postdoctoral training at the Scripps Research Institute of La Jolla in the area of tumor immunology
  • 2000 Clinical and Research Fellow of the Department of pediatric and adolescent medicine (focus on bone marrow transplantation) at the Charite University Hospital Berlin
  • 2003 Obtaining specialization in pediatrics
  • 2003 Habilitation and a teaching license in pediatrics at the Charite University Hospital Berlin
  • 2005 Additional qualification in pediatric intensive care
  • 2006 Received additional qualifications in the field of pediatric hematology and oncology
Experience
  • 1999-2000 Assistant Professor of the Department of immunology, tumor immunology laboratory at the Scripps Research Institute
  • 2000-2004 Department of pediatrics at the Charite University Hospital in Berlin
  • University Hospital Berlin
  • 2004-2005 Managing Senior Physician of the Department of pediatrics at the Charite University Hospital in Berlin
  • 2005-2009 Deputy Head of the Department of pediatrics at the Charite University Hospital in Berlin
  • University Hospital Berlin
  • 2008 Extraordinary professorship at the Charite University Hospital Berlin
  • 2009 Director of the Department of pediatrics at the University Hospital Greifswald
  • 2010 W3 Professor of the Department of pediatrics at the University Hospital Greifswald
Awards & Memberships
  • 1999 Junior Faculty Member at Scripps
  • 2002 Member of the International Society of Pediatric Oncology Europe Neuroblastoma group
  • 2005 Science4life Award, Venture Cup
  • 2013 Member of the scientific program advisory committee from the International Society for Pediatric Oncology Europe Neuroblastoma
  • Member of the German Society for Children and Adolescent Medicine
  • Member of the German Society of Pediatric Hematology and Oncology
  • Member of the International Society for Pediatric Oncology Europe Neuroblastoma
  • Member of the American Association for Cancer Research, the American Society of Hematology
  • Member of the American Association of Immunologists
  • Member of the American Society of Clinical Oncology
  • Chair of the immunotherapy committee from the International Society for Pediatric Oncology Europe Neuroblastoma
  • Member of the executive board of the International Society for Pediatric Oncology Europe Neuroblastoma
  • Reviewer in the following scientific journals: The Journal of Immunology, Blood, Cancer Research, Cancer Gene Therapy, Clinical Cancer Research, Oncogene

Languages

English flag
English
German flag
German

Publications

Endoscope-assisted microsurgical resection of a third ventricular immature teratoma.

4 July, 2023

Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy.

27 June, 2023

Combined Blockade of TIGIT and PD-L1 Enhances Anti-Neuroblastoma Efficacy of GD2-Directed Immunotherapy with Dinutuximab Beta.

23 June, 2023

FAQ

Where does the doctor practice?

What is the specialization of Prof. Dr. med. Holger Lode?

The primary specialization of the doctor is pediatrics, pediatric hematology and oncology, intensive care.

What is the experience of the specialist?

Prof. Dr. med. Holger Lode has been practicing for more than 31 years.

What is the rating of the doctor?

What topics does Prof. Dr. med. Holger Lode expert at?

The doctor has excellent knowledge in neuroblastoma, antibody, immunotherapy, cancer, dinutuximab.

Is the specialist involved in the research?

Does the specialist offer online consultations?

No, Prof. Dr. med. Holger Lode doesn’t perform virtual appointments.

Prof. Dr. med. Holger Lode
Prof. Dr. med. Holger Lode

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Prof. Dr. med. Holger Lode

Similar Doctors

Prof. Dr. med. Florian Heidel
Excellent
AiroScore
9.90
University Hospital Greifswald
internal medicine, hematology, and oncology
Prof. Dr. med. Christian A. Schmidt
Excellent
AiroScore
9.90
Prof. Dr. med. Vera Schellerer
Excellent
AiroScore
9.90
University Hospital Greifswald
general, visceral, and pediatric surgery
Prof. Dr. med. Mathias Heckmann
Excellent
AiroScore
9.90
Prof. Dr. med. Felix Berger
Excellent
AiroScore
10.00
University Hospital Charite Berlin
pediatrics, cardiology, congenital heart defects
Prof. Dr. med. Karin Rothe
Excellent
AiroScore
10.00
University Hospital Charite Berlin
paediatric surgery, general and reconstructive surgery
Prof. Dr. med. Klemens Raile
Excellent
AiroScore
10.00
Prof. Dr. med. Markus Mall
Excellent
AiroScore
10.00
University Hospital Charite Berlin
pediatrics, pulmonology, immunology, cystic fibrosis
Prof. Dr. med. Lars Bullinger
Excellent
AiroScore
10.00
University Hospital Charite Berlin
haematology, oncology, leukaemia research, tumor immunology